These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29426578)

  • 1. TGF-β signalling defect is linked to low CD39 expression on regulatory T cells and methotrexate resistance in rheumatoid arthritis.
    Peres RS; Donate PB; Talbot J; Cecilio NT; Lobo PR; Machado CC; Lima KWA; Oliveira RD; Carregaro V; Nakaya HI; Cunha TM; Alves-Filho JC; Liew FY; Louzada-Junior P; Cunha FQ
    J Autoimmun; 2018 Jun; 90():49-58. PubMed ID: 29426578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis.
    Peres RS; Liew FY; Talbot J; Carregaro V; Oliveira RD; Almeida SL; França RF; Donate PB; Pinto LG; Ferreira FI; Costa DL; Demarque DP; Gouvea DR; Lopes NP; Queiroz RH; Silva JS; Figueiredo F; Alves-Filho JC; Cunha TM; Ferreira SH; Louzada-Junior P; Cunha FQ
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2509-14. PubMed ID: 25675517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis.
    Gupta V; Katiyar S; Singh A; Misra R; Aggarwal A
    Int J Rheum Dis; 2018 Aug; 21(8):1548-1556. PubMed ID: 30146748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD39 expression on immune cells predicts methotrexate response in rheumatoid arthritis patients.
    Boral B; Tuncer İ; Kibar F; Çetiner S; Badak SÖ; Salman E; Koç E; Erken E; Yaman A
    Turk J Med Sci; 2023; 53(5):1075-1083. PubMed ID: 38813034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.
    Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T
    Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD39+ regulatory T cells suppress generation and differentiation of Th17 cells in human malignant pleural effusion via a LAP-dependent mechanism.
    Ye ZJ; Zhou Q; Zhang JC; Li X; Wu C; Qin SM; Xin JB; Shi HZ
    Respir Res; 2011 Jun; 12(1):77. PubMed ID: 21663645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T cells regulate the distribution of natural killer T cells through CD39 signal transduction in asthma.
    Lu Y; Li Y; Zhou W; Ding B; Yu Q
    Hum Cell; 2019 Apr; 32(2):141-149. PubMed ID: 30539423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD39+ regulatory T cells attenuate allergic airway inflammation.
    Li P; Gao Y; Cao J; Wang W; Chen Y; Zhang G; Robson SC; Wu Y; Yang J
    Clin Exp Allergy; 2015 Jun; 45(6):1126-37. PubMed ID: 25728362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation.
    Rissiek A; Baumann I; Cuapio A; Mautner A; Kolster M; Arck PC; Dodge-Khatami A; Mittrücker HW; Koch-Nolte F; Haag F; Tolosa E
    J Autoimmun; 2015 Apr; 58():12-20. PubMed ID: 25640206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mdivi-1 Protects Against Ischemic Brain Injury via Elevating Extracellular Adenosine in a cAMP/CREB-CD39-Dependent Manner.
    Cui M; Ding H; Chen F; Zhao Y; Yang Q; Dong Q
    Mol Neurobiol; 2016 Jan; 53(1):240-253. PubMed ID: 25428621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a Type 2-Polarized T Cell Phenotype With Methotrexate Nonresponse in Patients With Rheumatoid Arthritis.
    Slauenwhite D; McAlpine SM; Hanly JG; Malik A; Haidl ID; Marshall JS; Issekutz TB
    Arthritis Rheumatol; 2020 Jul; 72(7):1091-1102. PubMed ID: 32039570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis.
    Vuerich M; Harshe R; Frank LA; Mukherjee S; Gromova B; Csizmadia E; Nasser IAM; Ma Y; Bonder A; Patwardhan V; Robson SC; Longhi MS
    J Hepatol; 2021 Jan; 74(1):48-57. PubMed ID: 32663496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism of Foxp3 gene affects the frequency of regulatory T cells and disease activity in patients with rheumatoid arthritis in Iranian population.
    Hashemi V; Farrokhi AS; Tanomand A; Babaloo Z; Hojjat-Farsangi M; Anvari E; Tahoori MT; Ezzeddini R; Hosseini A; Gharibi T; Ghalamfarsa G; Jadidi-Niaragh F
    Immunol Lett; 2018 Dec; 204():16-22. PubMed ID: 30292536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Increased percentage and defective inhibitory function of CD4
    Zhang R; Miao J; Zhang K; Zheng Z; Zhu P
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):961-966. PubMed ID: 31878990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cells from Patients with Rheumatoid Arthritis Show Conserved CD39-Mediated Regulatory Function and increased CD39 Expression After Positive Response to Therapy.
    Zacca ER; Amezcua Vesely MC; Ferrero PV; Acosta CDV; Ponce NE; Bossio SN; Mussano E; Onetti L; Cadile I; Acosta Rodríguez EV; Montes CL; Gruppi A
    J Mol Biol; 2021 Jan; 433(1):166687. PubMed ID: 33098857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated regulatory T-cells attenuate myocardial ischaemia/reperfusion injury through a CD39-dependent mechanism.
    Xia N; Jiao J; Tang TT; Lv BJ; Lu YZ; Wang KJ; Zhu ZF; Mao XB; Nie SF; Wang Q; Tu X; Xiao H; Liao YH; Shi GP; Cheng X
    Clin Sci (Lond); 2015 May; 128(10):679-93. PubMed ID: 25558978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human CD39
    Gu J; Ni X; Pan X; Lu H; Lu Y; Zhao J; Guo Zheng S; Hippen KL; Wang X; Lu L
    Cell Mol Immunol; 2017 Jun; 14(6):521-528. PubMed ID: 27374793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice.
    Sun X; Wu Y; Gao W; Enjyoji K; Csizmadia E; Müller CE; Murakami T; Robson SC
    Gastroenterology; 2010 Sep; 139(3):1030-40. PubMed ID: 20546740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypical analysis of ectoenzymes CD39/CD73 and adenosine receptor 2A in CD4
    Han L; Sugiyama H; Zhang Q; Yan K; Fang X; McCormick TS; Cooper KD; Huang Q
    Australas J Dermatol; 2018 Feb; 59(1):e31-e38. PubMed ID: 28295154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine.
    Kapetanovic MC; Nagel J; Nordström I; Saxne T; Geborek P; Rudin A
    Vaccine; 2017 Feb; 35(6):903-908. PubMed ID: 28081972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.